Sign Out
No interactions with other drugs or nutritional products are known to date.
Consideration should be given to the concomitant administration of medicinal products that can cause potassium or sodium retention.
Elevated serum amylase levels may be observed temporarily following administration of the product and can interfere with the diagnosis of pancreatitis.
At high dosages the dilutional effects may result in decreased levels of coagulation factors and other plasma proteins and a decrease in haematocrit.
